BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

PsiOxus Therapeutics Limited 

Cherwell Innovation Centre
Unit 77, Heyford Park
Upper Heyford  Oxfordshire  OX25 5HD  United Kingdom
Phone: 44-(0)1869-238069 Fax: 44-(0)1869-238001


SEARCH JOBS




Industry
Biotechnology






 Company News
PsiOxus Therapeutics Limited Select BioOutsource To Support Clinical Sample Analysis For OCTAVE Ovarian Cancer Study 6/19/2014 9:10:34 AM
PsiOxus Therapeutics Limited Initiates "OCTAVE" Ovarian Cancer Study For Oncolytic Vaccine Enadenotucirev 6/17/2014 11:24:18 AM
PsiOxus Therapeutics Limited Announces Positive Study Results Of Oncolytic Vaccine Enadenotucirev At 2014 American Society of Clinical Oncology Annual Meeting 6/3/2014 6:45:40 AM
PsiOxus Therapeutics Limited To Release Study Results Of Oncolytic Vaccine Enadenotucirev In Cancer Patients 5/13/2014 8:44:44 AM
PsiOxus Therapeutics Limited Cancer-Wasting Drug Better Than Placebo In Phase 2 Study 11/12/2013 8:54:49 AM
BioIndustry Association Congratulates UK Company PsiOxus Therapeutics Limited on Being Named EuropaBio's Most Innovative European Biotech SME 10/3/2013 9:36:39 AM
PsiOxus Therapeutics Limited Completes Patient Enrollment for Phase II Wasting Disease Therapeutic MT-102 3/4/2013 10:30:04 AM
DTRA Awards $3.3 Million Contract to PsiOxus Therapeutics Limited to Develop Biodefence Vaccine Adjuvants 1/16/2013 9:08:14 AM
IXICO and PsiOxus Therapeutics Limited Win Significant Funding From Government-Backed Biomedical Catalyst 11/5/2012 3:25:16 PM
UK Government Awards £1.7 Million Grant to PsiOxus Therapeutics Limited for Second Phase I/II Clinical Trial of Cancer Vaccine 11/5/2012 10:58:02 AM
12